FindMyKOL
Clinical trialNCT01831219CompletedObservational

ROBODOC® Clinical Trials: Long-Term Follow-Up

NCT01831219 is an observational study sponsored by Curexo Technology Corporation. As of 21 Nov 2026, it is completed. It studies Osteoarthritis. The registry lists an enrollment of 118 participants at 1 site in 1 country. The registry lists a start date of 30 Apr 2013 and a primary completion date of 31 Jan 2016.

SponsorCurexo Technology CorporationEnrollment118Osteoarthritis
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01831219
FieldValue
Registry IDNCT01831219
StatusCompleted
Study typeObservational study
Lead sponsorCurexo Technology Corporation
Enrollment118
Registered sites1
Countries1
ConditionsOsteoarthritis
Start30 Apr 2013
Primary completion31 Jan 2016
Study completion31 Jan 2016
Last update posted11 Jan 2017

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a follow-up study looking at the and long-term results of two methods of preparing the thigh bone to receive an implant during hip replacement surgery. For one group of patients in the original study, the surgeon used a cutting tool called a broach and a special hammer on patients who had standard hip replacement operations. For the other patients, the surgeon used a surgical robot which was equipped with a cutting tool, like a drill, to prepare the thigh bone. The purpose of this study is to collect additional information confirming that the surgical robot is safe and effective when used as recommended. Only patients who were enrolled in the original clinical trials are eligible for this study.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • William L Bargar, MD

    Department of Orthopaedics, University of California at Davis

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • Sutter Institute for Medical Research

    Sacramento

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01831219

Each answer restates registry values shown on this page.

What is NCT01831219?

NCT01831219 is an observational study sponsored by Curexo Technology Corporation. It studies Osteoarthritis.

Who leads NCT01831219?

The registry names William L Bargar, MD (principal investigator, Department of Orthopaedics, University of California at Davis) as the overall official.

Where does NCT01831219 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT01831219 end?

The registry lists a primary completion date of 31 Jan 2016 and a study completion date of 31 Jan 2016. The sponsor last updated the record on 11 Jan 2017.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.